Patent details

EP3325008 Title: IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATED CAPSULAR SACCHARIDE ANTIGENS, KITS COMPRISING THE SAME AND USES THEREOF

Basic Information

Publication number:
EP3325008
PCT Application Number:
IB2016054217
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP167416957
PCT Publication Number:
WO2017013548
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATED CAPSULAR SACCHARIDE ANTIGENS, KITS COMPRISING THE SAME AND USES THEREOF
French Title of Invention:
COMPOSITIONS IMMUNOGÈNES CONTENANT DES ANTIGÈNES SACCHARIDIQUES CAPSULAIRES CONJUGUÉS, KITS COMPRENANT CES COMPOSITIONS ET LEURS UTILISATIONS
German Title of Invention:
IMMUNOGENE ZUSAMMENSETZUNGEN MIT KONJUGIERTEN KAPSELSACCHARID-ANTIGENEN, KITS DAMIT UND VERWENDUNGEN DAVON
SPC Number:

Dates

Filing date:
18/07/2016
Grant date:
10/09/2025
EP Publication Date:
30/05/2018
PCT Publication Date:
26/01/2017
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
10/09/2025
EP B1 Publication Date:
10/09/2025
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
18/07/2036
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
03/09/2025
 
 

Name:
Pfizer Inc.
Address:
66 Hudson Boulevard East, New York, NY 10001-2192, United States (US)

Inventor

1

Name:
JODAR MARTIN-MONTALVO, Luis Pascual
Address:
United States (US)

2

Name:
WATSON, Wendy Jo
Address:
United States (US)

3

Name:
ISTURIZ, Raul Enrique
Address:
United States (US)

4

Name:
REINERT, Ralf Rene
Address:
Germany (DE)

Priority

Priority Number:
201562194965 P
Priority Date:
21/07/2015
Priority Country:
United States (US)

Classification

IPC classification:
A61K 39/09; A61K 39/385; A61K 39/00;

Publication

European Patent Bulletin

1

Issue number:
202537
Publication date:
10/09/2025
Description:
Grant (B1)

2

Issue number:
202540
Publication date:
01/10/2025
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
31/07/2026
Annual Fee Number:
11
Annual Fee Amount:
148 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages